https://news.alfafinderusa.com/news/watsco-granite-group-holdings-acquisition-505-million-deal/ALFA USA Newsen2026-10-14T16:10:37-04:00Watsco Finalizes $505 Million Acquisition of Granite Group Holdingshttps://news.alfafinderusa.com/news/mubadala-capital-completes-clear-channel-outdoor-acquisition-6-2-billion/ALFA USA Newsen2026-10-14T15:34:37-04:00Mubadala Capital Completes $6.2 Billion Acquisition of Clear Channel Outdoor Holdingshttps://news.alfafinderusa.com/news/ultragenyx-rare-divest-fda-priority-review-voucher-203-million/ALFA USA Newsen2026-10-14T10:31:35-04:00Ultragenyx (RARE) to Divest FDA Priority Review Voucher for $203 Million in Cashhttps://news.alfafinderusa.com/news/skyx-platforms-completes-deako-acquisition-ma-deal/ALFA USA Newsen2026-10-14T10:18:05-04:00SKYX Platforms Completes Deako, Inc. Acquisition in $12.5 Million Cash and Note Dealhttps://news.alfafinderusa.com/news/sono-tek-corp-q2-2026-results/ALFA USA Newsen2026-10-14T10:04:04-04:00Sono-Tek Corp Reports Q2 Revenue Growth to $5.23 Million Despite Net Income Diphttps://news.alfafinderusa.com/news/pulse-biosciences-clayman-thyroid-partnership-npulse-vybrance/ALFA USA Newsen2026-10-14T09:52:34-04:00Pulse Biosciences Partners With Clayman Thyroid Center for nPulse Vybrance Deploymenthttps://news.alfafinderusa.com/news/vir-biotechnology-gilead-sciences-oncology-collaboration-t-cell-engagers/ALFA USA Newsen2026-10-14T09:38:04-04:00Vir Biotechnology Signs $1.875 Billion Gilead Oncology Collaborationhttps://news.alfafinderusa.com/news/cytodyn-inc-q1-2026-results-net-loss/ALFA USA Newsen2026-10-14T09:24:34-04:00CytoDyn Reports Q1 2026 Net Loss of $19.9 Million Amid Debt Extinguishmenthttps://news.alfafinderusa.com/news/flex-completes-1-1-billion-epc-power-acquisition-ai-infrastructure/ALFA USA Newsen2026-10-14T09:12:34-04:00Flex Ltd. Completes $1.1 Billion EPC Power Acquisition to Scale AI Infrastructurehttps://news.alfafinderusa.com/news/jingbo-technology-q2-2026-results/ALFA USA Newsen2026-10-14T09:00:34-04:00Jingbo Technology Narrowed Net Loss to $0.51 Million in Q2 2026 Despite Revenue Diphttps://news.alfafinderusa.com/news/profound-medical-tulsa-pro-clinical-data-imri-symposium-2026/ALFA USA Newsen2026-10-14T08:48:34-04:00Profound Medical Data Shows TULSA-PRO Superiority in Erectile Function Preservationhttps://news.alfafinderusa.com/news/fermi-frmi-tensorwave-contract-win-6-5-billion/ALFA USA Newsen2026-10-14T08:38:04-04:00Fermi Inc. Secures $6.5 Billion Turnkey Lease Agreement with TensorWavehttps://news.alfafinderusa.com/news/strive-asst-369-million-warrant-exercise-bitcoin-purchase/ALFA USA Newsen2026-10-14T08:23:04-04:00Strive, Inc. Generates $369.2 Million from Warrants to Expand Bitcoin Treasuryhttps://news.alfafinderusa.com/news/ankam-inc-q3-2026-results/ALFA USA Newsen2026-10-14T08:10:04-04:00Ankam, Inc. Q3 2026 Results: Net Loss Widens to $0.11 Million on Zero Revenuehttps://news.alfafinderusa.com/news/entrada-therapeutics-trda-dmd-clinical-trial-results-elevate-45-201/ALFA USA Newsen2026-10-14T07:57:04-04:00Entrada Therapeutics Reports Positive Topline Data for DMD Treatment ENTR-601-45https://news.alfafinderusa.com/news/aquestive-therapeutics-eton-pharmaceuticals-licensing-deal-libervant/ALFA USA Newsen2026-10-14T07:30:34-04:00Aquestive Therapeutics Secures $57.5 Million Licensing Deal with Eton Pharmaceuticalshttps://news.alfafinderusa.com/news/eton-pharmaceuticals-libervant-licensing-deal-aquestive-therapeutics/ALFA USA Newsen2026-10-14T07:18:04-04:00Eton Pharmaceuticals Shares Rise 5% After Securing U.S. Rights to LIBERVANThttps://news.alfafinderusa.com/news/fortunex-acquisition-fxac-wt-realty-merger-valuation-amendment/ALFA USA Newsen2026-10-14T06:27:34-04:00FortuneX Acquisition FXAC Amends WT Realty Merger Terms to $525 Million Valuehttps://news.alfafinderusa.com/news/integral-technologies-inc-fy-2026-financial-results/ALFA USA Newsen2026-10-14T06:16:04-04:00Integral Technologies Inc Reports $0.78 Million Net Loss for Fiscal 2026https://news.alfafinderusa.com/news/pioneer-acquisition-corp-green-ai-cloud-merger-300-million/ALFA USA Newsen2026-10-14T06:02:04-04:00Pioneer Acquisition I Corp to Merge with Green AI Cloud in $300 Million SPAC Dealhttps://news.alfafinderusa.com/news/atii-holdings-amends-100-million-pipe-deal-forge-nano-merger/ALFA USA Newsen2026-10-13T16:19:36-04:00ATII Holdings Amends $100 Million PIPE Deal for Forge Nano Mergerhttps://news.alfafinderusa.com/news/qums-fortune-favor-merger-600-million/ALFA USA Newsen2026-10-13T16:07:36-04:00Quantumsphere Acquisition Corp to Merge with Fortune Favor in $600 Million Dealhttps://news.alfafinderusa.com/news/ssr-mining-roxmore-resources-acquisition-nevada-gold-synergies/ALFA USA Newsen2026-10-13T10:22:41-04:00SSR Mining to Acquire Roxmore Resources in $464 Million Strategic Nevada Expansionhttps://news.alfafinderusa.com/news/ithaca-holdings-to-acquire-bumble-inc-1-3-billion-cash-deal/ALFA USA Newsen2026-10-13T10:10:10-04:00Bumble Shares Skyrocket 56% After Ithaca Holdings to Acquire Company in $1.3 Billion Dealhttps://news.alfafinderusa.com/news/ondas-inc-q2-2026-earnings-revenue-growth-guidance-update/ALFA USA Newsen2026-10-13T09:57:40-04:00Ondas Inc. Reports Q2 Revenue Surge to $83.8 Million and Raises 2026 Guidancehttps://news.alfafinderusa.com/news/ondas-palantir-launch-regna-ai-sovereign-defense-intelligence/ALFA USA Newsen2026-10-13T09:42:55-04:00Ondas Inc. and Palantir Launch Regna AI to Deliver Sovereign Defense Intelligencehttps://news.alfafinderusa.com/news/sab-biotherapeutics-sabs-fda-fast-track-sab-142-diabetes-immunotherapy/ALFA USA Newsen2026-10-13T09:29:25-04:00SAB Biotherapeutics (SABS) Secures FDA Fast Track for SAB-142 Diabetes Immunotherapyhttps://news.alfafinderusa.com/news/first-tracks-biotherapeutics-trax-celiac-disease-phase-1b-data/ALFA USA Newsen2026-10-13T09:15:25-04:00First Tracks Biotherapeutics Shares Surge 6.91% on Positive Phase 1b Celiac Disease Datahttps://news.alfafinderusa.com/news/eightco-holdings-orbs-nasdaq-compliance-october-2026/ALFA USA Newsen2026-10-13T09:03:25-04:00Eightco Holdings Inc. Regains Nasdaq Compliance After Ten-Day $1.00 Price Streakhttps://news.alfafinderusa.com/news/mirum-pharmaceuticals-mirm-phase-3-expand-results-livmarli-2026/ALFA USA Newsen2026-10-13T08:48:25-04:00Mirum Pharmaceuticals Meets Phase 3 EXPAND Endpoints for LIVMARLI; sNDA Planned for 2027https://news.alfafinderusa.com/news/kimberly-clark-kenvue-acquisition-7-billion-debt-exchange/ALFA USA Newsen2026-10-13T08:33:25-04:00Kimberly-Clark Advances $48.7 Billion Kenvue Acquisition with $7 Billion Debt Exchangehttps://news.alfafinderusa.com/news/ttm-technologies-q2-2026-earnings-analysis-data-center-growth/ALFA USA Newsen2026-10-13T08:20:25-04:00TTM Technologies Reports Record Q2 2026 Revenue of $1 Billion Amid Data Center Surgehttps://news.alfafinderusa.com/news/norris-industries-q2-2026-results-analysis/ALFA USA Newsen2026-10-13T08:09:55-04:00Norris Industries Reports $0.09 Million Q2 Revenue Amid Widening Net Losshttps://news.alfafinderusa.com/news/adct-therapeutics-capital-raise-86-million-zynlonta-pipeline/ALFA USA Newsen2026-10-13T07:56:25-04:00ADC Therapeutics Secures $86.6 Million PIPE to Extend Cash Runway into 2029https://news.alfafinderusa.com/news/nurix-therapeutics-q3-2026-results/ALFA USA Newsen2026-10-13T07:43:25-04:00Nurix Therapeutics Swings to $549.8M Net Income in Q3 2026 on License Revenue Surgehttps://news.alfafinderusa.com/news/ionq-q2-2026-revenue-growth-skywater-acquisition/ALFA USA Newsen2026-10-13T07:32:55-04:00IonQ Reports 287 Percent Revenue Surge to $80.1 Million Following SkyWater Mergerhttps://news.alfafinderusa.com/news/oz-vision-inc-fy-2026-financial-results/ALFA USA Newsen2026-10-13T07:22:24-04:00OZ Vision Inc. Reports $0.05 Million Revenue and 10.6% Net Loss Improvement for FY 2026https://news.alfafinderusa.com/news/ttm-technologies-400-million-ai-infrastructure-expansion-china-malaysia/ALFA USA Newsen2026-10-13T07:07:54-04:00TTM Technologies Shares Rise 5% After Investing $400 Million to Scale AI Infrastructurehttps://news.alfafinderusa.com/news/dominos-pizza-dpz-q3-2026-financial-results/ALFA USA Newsen2026-10-13T06:56:24-04:00Domino's Pizza Reports $1.19 Billion Revenue and 9.2% Net Income Growth for Q3 2026https://news.alfafinderusa.com/news/humana-blackrock-centerwell-partnership-2-8-billion-joint-venture/ALFA USA Newsen2026-10-13T06:42:24-04:00Humana Partners with BlackRock in $2.8 Billion CenterWell Primary Care Joint Venturehttps://news.alfafinderusa.com/news/ionq-acquires-elisity-1-3-billion-quantum-security-deal/ALFA USA Newsen2026-10-13T06:27:24-04:00IonQ to Acquire Zero Trust Leader Elisity in $1.3 Billion All-Stock Transactionhttps://news.alfafinderusa.com/news/zhanling-international-ltd-q1-2026-results/ALFA USA Newsen2026-10-13T06:15:54-04:00Zhanling International Ltd Narrowed Net Loss to $0.01 Million in Q1 2026https://news.alfafinderusa.com/news/zenas-biopharma-zbio-obexelimab-phase-3-indigo-data-igg4-rd/ALFA USA Newsen2026-10-13T06:04:24-04:00Zenas BioPharma Reports 93% Flare-Free Rate in Phase 3 INDIGO Extension Study